SEC Form 4 · accession 0001610717-26-000349
Omada Health, Inc. · OMDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean P. Duffy
Officer — Chief Executive Officer · Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:59 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001611115
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2026 | M | 12,944 | $5.82 | A | 424,805 | D | |
| Common StockF2 | Aug 3, 2026 | S | 12,944 | $20.3961 | D | 411,861 | D | |
| Common StockF3 | holding | — | — | — | 851,659 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $5.82 | Aug 3, 2026 | M | 12,944 | D | — | Aug 21, 2029 | Common Stock | 12,944 | 142,483 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2This transaction was executed in multiple trades at prices ranging from $20.15 to $20.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F4100% of the shares subject to the option are fully vested and exercisable.